Landmark Study Reveals Low Bacterial STI Rates Among Auckland Sex Workers

A groundbreaking study published in the New Zealand Medical Journal (NZMJ) on March 13, 2026, has shed new light on sexually transmitted and blood-borne infections (STBBI) among sex workers in Auckland. Titled "Diagnoses of blood-borne viruses and other sexually transmitted infections in a sample of 356 sex workers attending a sexual health outreach clinic in Auckland over a two-year period," the research by Dr. Sunita Azariah from Auckland Sexual Health Service provides the largest dataset yet on this priority population in New Zealand.

The findings challenge longstanding stigmas, showing that cisgender female sex workers had lower rates of chlamydia and gonorrhoea compared to women attending general sexual health clinics. However, notable prevalence of past or current hepatitis C infection underscores the need for targeted screening and support. This research arrives amid rising STBBI notifications nationally, highlighting the value of accessible outreach services.

New Zealand's Decriminalization Model: A Public Health Success?

New Zealand's Prostitution Reform Act (PRA) of 2003 decriminalized sex work, aiming to safeguard workers' rights, health, and safety. Unlike criminalized models elsewhere, this approach has fostered better access to services, reducing barriers to testing and care. The Aotearoa New Zealand Sex Workers' Collective (NZPC), a key advocate, partners with health services like Auckland Sexual Health Service (ASHS) for weekly nurse-led clinics at its Auckland offices. These free, confidential sessions offer comprehensive STBBI screening, reflecting a harm-reduction ethos.

Post-PRA evaluations, including a 2008 government report, noted improved condom use and health practices. Sex workers reported fewer STIs and violence, attributing gains to destigmatization. Yet vulnerabilities persist for street-based or migrant workers, who face higher risks. The NZMJ study, conducted from late 2018 to 2020 (overlapping early COVID-19), builds on this by quantifying outcomes in a real-world outreach setting.

Study Methodology: Capturing a Vulnerable Cohort

Dr. Azariah analyzed data from 356 unique sex workers attending the NZPC-ASHS outreach clinic. The sample was predominantly cisgender females (93.5%, n=333), with transgender females (3.9%, n=14), cisgender males (3.9%, n=7), and one transgender male. Median age was 31 years; ethnicities included New Zealand/other European (42.7%), Māori (17.4%), Asian (24.4%), Pacific (4.2%), and other (10.7%).

Tests encompassed HIV/syphilis serology, chlamydia/gonorrhoea NAAT at multiple sites (oropharynx, urogenital, anorectal), and selective hepatitis B/C based on risk. Positive rates were calculated as positives per tests requested, not per person, due to repeat visits. Comparators included ASHS general clinic data (2019-2020) and population-based Auckland surveillance (PHF Science). Ethics approval ensured participant safety, with NZPC input guiding the process. Note: Participants were outreach attendees, potentially more vulnerable than indoor workers, limiting generalizability.

Bacterial STIs: Lower Than Clinic Averages

Chlamydia test-positivity was 4.9% overall, with 5.1% among cisgender females—below ASHS general female clinic rates (9.0%) and population females (6.3%). Gonorrhoea stood at 4.4% overall (3.9% cis-females), higher than population females (1.5%) but lower than clinic females (5.0%). Transgender females showed elevated rates: chlamydia 7.4%, gonorrhoea 12.7%.

• Of 32 gonorrhoea cases, 78% cis-females; sites: urogenital (69%), pharyngeal (41%), anorectal (3%). Māori (37.5%) and non-European ethnicities (59%) overrepresented.
• Syphilis: 2.6% reactive serology (16/615), but only 0.65% new diagnoses (4 cases: 3 cis-females, 1 male).

Nationally, chlamydia notifications hover around 500-600 per 100,000, gonorrhoea 150-200, syphilis rising (774 infectious cases 2024). Sex workers comprised just 1.6-1.8% of gonorrhoea/syphilis cases, suggesting effective prevention.

Photo by Josh Tere on Unsplash

Blood-Borne Viruses: No HIV, Concerning Hep C

No new HIV diagnoses (all 615 negative; one known case on treatment). Hepatitis B: Of 253 tested, 48% immune, 36% susceptible, 3 chronic (1.2%, Asian ethnicity). Hepatitis C antibody testing (159/356, 44%): 15.7% positive; 4.4% RNA-positive (current infection). Only 16% of positives had treatment history; 20% injecting drug use noted.

General NZ Hep C viraemia ~0.35% (18,000 cases 2023), higher in prisons/drug users. Study urges routine Hep C screening in sex workers, as direct-acting antivirals cure >95%.NZMJ Study Intersection with methamphetamine (11%) and injecting (1%) heightens risk.

Comparisons and National Context

The study's cis-female rates beat clinic benchmarks, aligning with PRA benefits: regular testing, peer education. Nationally, Māori/Pacific bear disproportionate STBBI burden (e.g., syphilis Māori infants 23/100k vs national 11). Auckland sees ~25% syphilis, 21% gonorrhoea cases.

Sources approximate population rates from trends; sex workers lower bacterial STIs but Hep C signals harm reduction needs.

Sex Workers' Proactive Health Practices

RNZ interviews reveal rigorous protocols: correct condom sizing/fit, compatible lube, handwashing, dental dams for oral. Testing every 3 months via GP/clinics; post-incident checks (e.g., broken condom). Industry incentives—no sick pay—drive vigilance. "STI means weeks off work," notes one worker.

• Change condoms mid-session if stretched.
• Water/silicone lube only (oil breaks latex).
• Inspect clients; discuss risks.
• NZPC education empowers.

Vulnerabilities and Intersections

Outreach clients skew vulnerable: higher Māori/Asian, drug use (meth 11%, injecting 1%). Street/migrant/trans workers face violence, inconsistent protection. COVID reduced volumes 20%, but rates held. Stigma lingers, despite PRA successes.

Photo by Niranjan Lamichhane on Unsplash

Public Health Implications and Recommendations

Study affirms sex workers not STI vectors; lower rates than general. Routine Hep C testing vital—cure available, under-treatment evident. NZ STBBI Strategy prioritizes them; expand outreach, destigmatize. Link to hep treatment/harm reduction.PHF STI Report 2024

For careers combating STBBIs, consider public health roles. Research jobs in NZ or career advice.

Future Outlook: Sustaining Gains Amid Rising National Trends

With syphilis/gonorrhoea climbing nationally, NZPC/ASHS model scalable. More male/trans data needed. Policy: fund outreach, PrEP/Hep C cures. Research: longitudinal STI tracking. Positive: decrim works; empower workers for health equity.

Explore opportunities at NZ higher ed jobs, higher ed jobs, rate professors.